Joshua H. Bilenker - 03 Feb 2021 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ Nathan Hardy, Attorney-in-Fact for Joshua H. Bilenker
Issuer symbol
SANA
Transactions as of
03 Feb 2021
Net transactions value
+$500,000
Form type
4
Filing time
17 Feb 2023, 16:17:55 UTC
Next filing
10 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Purchase $500,000 +20,000 $25.00 20,000 03 Feb 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.